Skip to main content
Premium Trial:

Request an Annual Quote

Geeta Vemuri, Thaddeus “Thad” Seymour

Quaker BioVentures Promotes Principal Geeta Vermuri to Partner
Geeta Vemuri has been promoted to partner at Quaker BioVentures, a Philadelphia venture capital firm dedicated to investing in life science companies in the Mid-Atlantic region.
Vemuri joined Quaker BioVentures as a senior associate in 2003, and was later promoted to vice president, then to her most recent position of principal. During that time, she led the firm to a number of investment commitments with early-stage biotherapeutic and healthcare companies.
Vermuri currently serves on the board of directors and executive committee of Southeast BIO; as well as the boards of Argolyn BioSciences, Cellatope, and Immune Control. She also serves as an advisory committee member for BioAdvance Greenhouse and the Sid Martin Biotechnology Incubator, as well as a board observer for Optherion, Regado, Tengion, and Tranzyme.
Before joining Quaker, Vemuri was an associate at Toucan Capital, responsible for investments in seed and start-up biotech companies. Vemuri has also served as an associate analyst at Salomon Smith Barney, where she focused on specialty pharmaceuticals, and at First Union Securities, specializing in healthcare. Earlier in her career, she was a research scientist at The Wistar Institute and postdoctoral fellow at Thomas Jefferson University.
Vemuri received her MS degree from Central University in India, her PhD in biochemistry from the Indian Institute of Sciences, and her MBA from the Wharton School of the University of Pennsylvania.
Quaker BioVentures has $700 million under management.

Lake Nona Names Vice President and General Manager of Health and Life Science
Thaddeus “Thad” Seymour has been named vice president and general manager of health and life science investments for Lake Nona Property Holdings, the owner and developer of the Lake Nona mixed-use master planned community in Orlando, Fla.
Seymour will oversee strategic planning and business development initiatives surrounding Lake Nona’s 600-acre Science & Technology Park. Seymour will manage all life science strategy for the community, including corporate recruitment and synergies, strategic partnerships, new ventures and community collaboration.
Seymour previously served as a senior executive with CuraScript, the Orlando-based specialty pharmacy subsidiary of the pharmacy benefit management giant Express Scripts. Earlier, Seymour held senior leadership positions with IBAX Healthcare Systems, an IBM and Baxter Healthcare joint venture, and HBO & Co., now part of McKesson Corp. He also served as president of Avio Corp., a venture-backed developer of electronic medical records software, now owned by Siemens.
Seymour was a founding board member of bioOrlando and serves on the board of Florida’s Blood Centers. He is a past board member of the Crummer Entrepreneurship Center at Rollins College, and the Florida Venture Forum; a former trustee of Trinity Preparatory School; an assistant Boy Scout scoutmaster, and a 15-year officer of the Dartmouth Club of Central Florida.
He received an undergraduate degree from Dartmouth College, an MBA from the Kellogg Graduate School of Management at Northwestern University, and a PhD from the University of Wisconsin.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.